Aridis Pharmaceuticals Reports Positive Preclinical Efficacy Data of a Highly Effective Inhaled Treatment Supporting a Proposed Self-Administered Therapy for COVID-19 Patients
Stock Information for Aridis Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.